Bristol-Myers Squibb Company (FRA:BRM)
42.00
-0.26 (-0.60%)
At close: Dec 1, 2025
Bristol-Myers Squibb Company Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€1,200,568
Profits / Employee
€150,940
Market Cap
86.12B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34,100 | 0 | - |
| Dec 31, 2023 | 34,100 | -200 | -0.58% |
| Dec 31, 2022 | 34,300 | 2,100 | 6.52% |
| Dec 31, 2021 | 32,200 | 1,950 | 6.45% |
| Dec 31, 2020 | 30,250 | 250 | 0.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Bristol-Myers Squibb Company News
- 20 hours ago - Bristol Myers Squibb Unveils Positive Trial Data In Hematology Pipeline - Nasdaq
- 20 hours ago - Bristol Myers (BMY) Showcases Breakthroughs in Hematology at ASH Meeting - GuruFocus
- 21 hours ago - Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio - Wallstreet:Online
- 2 days ago - Should You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend? - The Motley Fool
- 3 days ago - Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? - Nasdaq
- 4 days ago - Bristol-Myers (BMY) Earnings Call Transcript - The Motley Fool
- 4 days ago - Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth? - Nasdaq
- 6 days ago - BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi - Nasdaq